Johnson & Johnson has no intention of developing obesity drugs and will focus on areas such as cancer.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Finance June 17｜Joaquin Duato, CEO of Johnson & Johnson, stated that Johnson & Johnson has no plans to enter the booming obesity drug market and instead chooses to focus on fields such as cancer.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Ark Research Director: Only 0.15% of revenue generated by Robinhood Chain flowed to Ethereum
Odaily星球日报•2026/07/14 02:09
Ark Invest added approximately $26.95 million worth of SpaceX and Block shares yesterday.
ForesightNews•2026/07/14 02:08
The Bank of Korea is Expected to Raise Interest Rates This Week for the First Time in Over Three Years
BlockBeats•2026/07/14 02:08
Crypto prices
More
Bitcoin
BTC
$62,510.29
-1.18%
Ethereum
ETH
$1,784.34
-1.04%
Tether USDt
USDT
$0.9989
-0.06%
USDC
USDC
$0.9999
+0.00%
XRP
XRP
$1.06
-1.26%
Solana
SOL
$75.21
-1.45%
TRON
TRX
$0.3241
-2.10%
Hyperliquid
HYPE
$63.3
-5.49%
Dogecoin
DOGE
$0.07190
-0.80%
Zcash
ZEC
$500.04
-5.07%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now